Meixia Zhang

Meixia Zhang

Auto-generated profile, based on publicly available information

Meixia Zhang

Department of Neurology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Radiology
Verified
Journal Article
Closed access
FSFeina Shi
Feina Shi
XGXiaoxian Gong
Xiaoxian Gong
CLChang Liu
Chang Liu
QZQiang Zeng
Qiang Zeng
MZMeixia Zhang
Meixia Zhang
MLMin Lou
Min Lou
The measurement of maximum cerebral blood flow in collateral vessels within the Sylvian fissure is an independent predictor for both hemorrhagic transformation and good outcome. Purpose To develop a quantitative assessment of collateral perfusion at CT and to investigate its value in the prediction of outcome in patients with acute ischemic stroke (AIS). Materials and Methods This retrospective study reviewed data from consecutive patients with AIS and an occluded M1 segment of the middle cerebral artery who underwent pretreatment perfusion CT between May 2009 and August 2017. The maximum cerebral blood flow (CBF) of collateral vessels (cCBFmax) within the Sylvian fissure was calculated for each patient. Good outcome was defined as a 90-day modified Rankin scale score of 0–2. Multivariable logistic regression analysis was used to determine the relationship between cCBFmax and (a) hemorrhagic transformation and (b) clinical outcome. Results The final analysis included 204 patients (median age, 73 years; interquartile range, 62–80 years; 82 [40.2%] women). Multivariable logistic regression analysis showed that higher cCBFmax was an independent predictor for (a) a lower risk of hemo...

11 December 2017 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
XZX. Zhang
X. Zhang
MZM. Zhang
M. Zhang
WDW. Ding
W. Ding
SYShenqiang Yan
Shenqiang Yan
DLD. S. Liebeskind
D. S. Liebeskind
MLMin Lou
Min Lou

15 February 2018 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
ZCzhicai chen
zhicai chen
FSF. Shi
F. Shi
MZM. Zhang
M. Zhang
XGX. Gong
X. Gong
LLLongting Lin
Longting Lin
MLMin Lou
Min Lou
BACKGROUND AND PURPOSE: The multisegment clot sign has been observed at the site of large-artery occlusion in patients with acute ischemic stroke. This study aimed to assess its occurrence rate and relationship with stroke etiologies in patients with acute intracranial large-artery occlusion. MATERIALS AND METHODS: We included consecutive patients with acute ischemic stroke who had acute intracranial large-artery occlusion and underwent perfusion CT within 8 hours after stroke onset. The multisegment clot sign was assessed on dynamic CT angiography derived from perfusion CT. The stroke etiologies were defined by the international Trial of Org 10172 in Acute Stroke Treatment criteria. Poisson regression analyses and diagnostic testing were used to investigate the relationship between the multisegment clot sign and stroke etiologies. RESULTS: Finally, 194 patients with intracranial large-artery occlusion were enrolled. According to the Trial of Org 10172 in Acute Stroke Treatment criteria, 110 (56.7%) patients were diagnosed with cardioembolism; 43 (22.2%), with large-artery atherosclerosis; and 41 (21.1%), with undetermined etiology. The multisegment clot sign was found in 74 (38%) patients. Poisson regression analysis showed that the presence of the multisegment clot sign was significantly higher in patients with cardioembolism than in those with large-artery atherosclerosis (52.7% versus 9.3%; prevalence ratio, 1.53; 95% confidence interval, 1.03–2.90; P = .037). For determined etiologies, the sensitivity, specificity, and positive and negative predictive values of the multisegment clot sign for predicting cardioembolism were 52.7%, 90.7%, 93.5%, and 42.9%, respectively. CONCLUSIONS: The presence of the multisegment clot sign on dynamic CTA specifically indicates intracranial large-artery occlusion caused by an embolism from a cardiac source, which may be useful for acute management and secondary prevention of stroke.

1 July 2017 in Medicine
Verified
Journal Article
Open access
PDF file
HSHujia Shen
Hujia Shen
SZSusu Zheng
Susu Zheng
RCRongxin Chen
Rongxin Chen
XJXuejuan Jin
Xuejuan Jin
XXXin Xu
Xin Xu
BZBoheng Zhang
Boheng Zhang
Although procalcitonin (PCT) is a valid marker for early diagnosis of bacterial infections, its accuracy in hepatocellular carcinoma (HCC) patients is unknown. The aim of this study was to investigate the prognostic significance of PCT in patients with unresectable HCC treated with transcatheter arterial chemoembolization (TACE). A total of 509 patients with unresectable HCC initially treated with TACE were enrolled in this retrospective study. According to quartile of the PCT values, all patients were divided into 4 groups. Overall survival (OS) was evaluated with the Kaplan–Meier method. Significant difference was estimated with the Log rank method. Univariate and multivariate analyses were used for evaluating the significance of the prognostic factor. The median follow-up period was 18 months and there were significant differences in the survival rates between the 4 groups. The HR (95% CI) for all-cause mortality comparing patients with PCT Quartile2–4 to patient with Quartile1 (HR = 1.00) were 1.353 (1.023–1.791), 1.799 (1.354–2.390), 1.960 (1.455–2.639), respectively, (P < .001). PCT level was an important prognostic factor for predicting the prognosis of patients with unresectable HCC treated with TACE.

8 September 2023 in Medicine
Verified
Journal Article
Open access
HCHongfang Chen
Hongfang Chen
JWJianwei Wang
Jianwei Wang
XPXiaoling Pan
Xiaoling Pan
MZMeixia Zhang
Meixia Zhang
Whether emergency medical service (EMS) improves the outcome of acute ischemic stroke (AIS) patients after intravenous thrombolysis (IVT) is still unknown among the severity of neurologic deficits. This study is to investigate the impact of EMS use on timely treatment and outcomes of AIS with IVT. This is a retrospective observational study. Clinical data after IVT from January 2017 to May 2020 were retrospectively analyzed, including onset-to-needle time (ONT), onset-to-door time (ODT). The patients were divided into EMS and non-EMS groups according to the method of admission. A good outcome was defined as a modified Rankin scale score of ≤2 at 3 months. The severity of neurological deficits was assessed using the national institutes of health stroke scale. A total of 2303 patients were analyzed (906 [(39.3%] female; mean age, 68 ± 13 year), and 1028 (44.6%) patients were transported by EMS and 1418 (67.9%) patients achieved good outcome. Among all patients, compared with non-EMS patients, EMS patients had shorter ONT (148 minutes vs 155 minutes, P = .002) and ODT (95 minutes vs 104 minutes, P < .001), but lower rate of good outcome (61.7% vs 73.0%, P < .001). The multivariate analysis showed that the use of EMS was negatively associated with ONT (ρ = −0.041, P = .048) and ODT (ρ = −0.051, P = .014). Among moderate to severe stroke patients, EMS was related with good outcome independently (OR: 3.101, 95%CI: 1.367–7.038, P = .007). In ischemic stroke, EMS can shorten the pre-hospital delay. Among moderate to severe stroke patients, EMS can further improve the outcome. But the study needs further validation.

23 February 2023 in medRxiv
Verified
Preprint
Open access
PDF file
XPXiaoling Pan
Xiaoling Pan
YPYingjian Pei
Yingjian Pei
MZMeixia Zhang
Meixia Zhang
WZWansi Zhong
Wansi Zhong
JHJin Hu
Jin Hu
ZCzhicai chen
zhicai chen
Objective To investigate the association of atrial fibrillation (AF), especially newly diagnosed AF, with remote intracerebral hemorrhage (rICH) in patients with ischemic stroke treated by intravenous thrombolysis. Methods This is an observational study of patients with ischemic stroke who were treated with intravenous thrombolysis with recombinant tissue-type plasminogen activator whose data were taken from a multicenter prospective registry of a Chinese population. RICH was defined as any extraischemic hemorrhage detected by imaging examination ≤ 24 hours after intravenous thrombolysis. We collected the demographic data and clinical characteristics of all the patients. We compared patients with rICH and those without any type of hemorrhagic transformation. The association of AF and rICH was analyzed by univariate analysis and binary logistic regression. Results We evaluated 20697 patients, 1566 (7.6%) of whom developed intracerebral hemorrhage (ICH), 586 (2.8%) of whom experienced rICH, and 19131 (92.4%) of whom did not experience any type of hemorrhagic transformation. Univariate analysis showed that there were significant differences in age, prethrombolysis systolic blood pressure, baseline NIHSS score, known AF, newly diagnosed AF, coronary heart disease, congestive heart failure, hyperhomocysteinemia and history of thrombolysis between the rICH and control groups (P < 0.05). Further multivariate logistic regression analysis showed that total AF [OR 1.821, (95%CI, 1.082-3.065), P < 0.05], known AF [OR 1.470, (95%CI, 1.170-1.847)] and newly diagnosed AF [OR 1.920, (95%CI, 1.304-2.825)] were all independently associated with rICH. Conclusions This study suggests that AF (regardless of the newly diagnosed or known AF) may be associated with the occurrence of rICH after intravenous thrombolysis. Interestingly, newly diagnosed AF may have a greater impact on rICH than known AF, but that finding needs to be confirmed by a larger prospective sample.